Adult Nodular Sclerosis Hodgkin Lymphoma Completed Phase 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00132028Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's LymphomaTreatment